Novel PCSK9 Inhibitor Recaticimab Lowers Lipids With Less Fr

Monoclonal antibody promises substantial lipid lowering with just one injection every 3 months

Related Keywords

Monash , South Australia , Australia , Chicago , Illinois , United States , Philadelphia , Pennsylvania , Melbourne , Victoria , China , American , Chinese , Nicole Lou , Donald Lloyd Jones , Stephen Nicholls , Karol Watson , American Heart Association , Monash Victorian Heart Institute , University Of California Los Angeles , Northwestern University Feinberg School Of Medicine , Beijing Anzhen Hospital , California Los Angeles , Northwestern University Feinberg School , Medpage Today ,